...
首页> 外文期刊>The Journal of arthroplasty >Symptomatic osteonecrosis of the hip after orthotopic liver transplantation.
【24h】

Symptomatic osteonecrosis of the hip after orthotopic liver transplantation.

机译:原位肝移植后髋关节症状性骨坏死。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients who require long-term steroid use for immunosuppression after organ transplantation are at risk for the development of osteonecrosis. The purpose of this study was to determine the prevalence of symptomatic osteonecrosis of the hip in patients who were managed with corticosteroids for immunosuppression after orthotopic liver transplantation. We reviewed the relationship of the administration and dosage of steroids in 203 patients who underwent orthotopic liver transplantation. Overall, 29 of the 203 patients (14%) complained of hip pain, but only 3 patients (2%) developed symptomatic osteonecrosis of the hip. The osteonecrosis was diagnosed an average of 31 months after transplantation (range, 26-38 months). There was no association noted between steroid dose and the development of osteonecrosis. Routine screening for osteonecrosis of asymptomatic liver transplant patients is not necessary.
机译:器官移植后需要长期使用类固醇进行免疫抑制的患者有发生骨坏死的风险。这项研究的目的是确定在原位肝移植后接受皮质类固醇激素免疫抑制治疗的患者中髋关节症状性骨坏死的患病率。我们回顾了203例接受原位肝移植的患者中类固醇的给药与剂量之间的关系。总体而言,203名患者中有29名(14%)抱怨髋关节疼痛,但只有3名患者(2%)出现了髋关节症状性骨坏死。移植后平均31个月(范围26-38个月)诊断出骨坏死。在类固醇剂量和骨坏死的发展之间没有关联。无需常规筛查无症状肝移植患者的骨坏死。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号